Answers are grounded in this paper and cite their sources.
Position paper demonstrates clinical imaging protocols in known or suspected cardiac sarcoidosis, highlighting standardized evaluation across multiple diagnostic modalities.
This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
No takes yet. Share an insight, caveat, or question.
group: et al. (2017) conducted a review in Cardiac sarcoidosis. Cardiac imaging (echocardiography, 18F-FDG PET, myocardial perfusion imaging, CMR) was evaluated. This joint position statement provides standardized flow charts and guidance on the use of echocardiography, 18F-FDG PET, myocardial perfusion imaging, and CMR for managing cardiac sarcoidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: